1. Current use of estrogen-containing oral contraceptives or hormone therapy and risk of COVID-19 infection and hospitalization: a population-based cohort study.
- Author
-
Harrington, Laura B, Powers, J David, Bayliss, Elizabeth A, Fortmann, Stephen P, Shortreed, Susan M, Walker, Rod L, Floyd, James S, Kuntz, Jennifer, Fuller, Sharon, Alberston-Junkans, Ladia, Lee, Mi H, Temposky, Lisa A, and Dublin, Sascha
- Subjects
- *
RISK assessment , *HORMONES , *RESEARCH funding , *HOSPITAL care , *LOGISTIC regression analysis , *ESTROGEN , *DESCRIPTIVE statistics , *ODDS ratio , *ORAL contraceptives , *HORMONE therapy , *CONFIDENCE intervals , *COVID-19 , *SARS-CoV-2 - Abstract
The association between current use of oral contraceptives (OCs) among women younger than 50 years (n = 306 541), and hormone therapy (HT) among women aged 50 years or older (n = 323 203), and coronavirus 2019 (COVID-19) infection and hospitalization was evaluated in this population-based cohort. Current OC/HT use was recorded monthly using prescription dispensing data. COVID-19 infections were identified from March 2020 through February 2021. COVID-19 infections and hospitalizations were identified through diagnosis codes and laboratory tests. We used weighted generalized estimating equations models to estimate multivariable adjusted odds ratios (aORs) for COVID-19 infection associated with time-varying OC/HT use. Among women with COVID-19, logistic regression models were used to evaluate OC/HT use and COVID-19 hospitalization. Over 12 months, 11 727 (3.8%) women younger than 50 years and 8661 (2.7%) women aged 50 years or older experienced COVID-19 infections. There was no evidence of an association between OC use and infection (aOR = 1.05; 95% CI, 0.97-1.12). There was a modest association between HT use and infection (aOR = 1.19; 95% CI, 1.03-1.38). Women using OCs had a 39% lower risk of hospitalization (aOR = 0.61; 95% CI, 0.38-1.00), but there was no association of HT use with hospitalization (aOR = 0.89; 95% CI, 0.51-1.53). These findings do not suggest a meaningfully greater risk of COVID-19 infection associated with OC or HT use. OC use may be associated with lower COVID-19 hospitalization risk. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF